This classification was further validated by the elevated expression of known ccRCC markers, including NDFA4L2, CA9, and MET, which were highly expressed in the malignant epithelial cells identified by CNV analysis, consistent with previous studies 57 (Figure 4I-J). The gene discussed is MET; the disease is nonpapillary renal cell carcinoma.